MedTrace Logo

SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications

NCT03062124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2021-05-20

No results posted yet for this study

Summary

Distinguishing intraductal papillary mucinous neoplasms (IPMNs) from other pancreatic cystic lesions is essential as IPMNs bear risk of becoming malignant. Differentiating the main pancreatic duct involving IPMNs (MD-IPMNs) with imaging can be difficult. Single-operator peroral pancreatoscopy (SOPP) has shown to be a promising method offering additional information on suspected lesions in the main pancreatic duct (MD). We aimed to establish the role of SOPP in preoperative diagnostics of presumed MD-IPMNs. A secondary objective was to identify factors that contribute to SOPP-related complications.

Conditions

  • Intraductal Papillary Mucinous Neoplasm

Interventions

PROCEDURE

SpyGlass pancreatoscopy

During the SpyGlass pancreatoscopy procedure visually guided biopsies and flushing liquid are collected from the pancreatic duct

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Sini M Vehviläinen, MD · Helsinki University Central Hospital

  • Hanna Seppänen, MD, PhD · Helsinki University Central Hospital

  • Marianne Udd, MD, PhD · Helsinki University Central Hospital

  • Outi Lindström, MD, PhD · Helsinki University Central Hospital

  • Leena Kylänpää, MD, PhD · Helsinki University Central Hospital

  • Urban Arnelo · Karolinska University Hospital

  • Niklas Fagerström · Karolinska University Hospital

  • Roberto Valente · Karolinska University Hospital

  • Harri Mustonen · Helsinki University Central Hospital

  • Fredrik Swahn · Skane University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-18
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Finland
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03062124 on ClinicalTrials.gov